Analyst flags key buy levels as Rossari, AstraZeneca break out

AstraZeneca Pharma and Rossari Biotech are flashing fresh breakout signals on strong Q1 metrics. Analyst Gunjan Kumar sees AstraZeneca forming an ascending triangle, advising a watch above Rs 9,350. Rossari, backed by increased FII/DII stakes, shows a trendline breakout above Rs 715. Both firms reported their best revenue in 13 quarters.